Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Donald W Degolyer

Director at Emergent BioSolutions Inc. (EBS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $444K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 7SEC EBSEmergent BioSolutions Inc. Sell Plan 17,800111,921 held (−14%) $7.09 $126K -10.0%
May 4SEC EBSEmergent BioSolutions Inc. Sell Plan 14,527130,675 held (−10%) $8.36 $121K -23.7%
May 4SEC EBSEmergent BioSolutions Inc. Sell Plan 954129,721 held (−1%) $8.96 $9K -28.8%
Nov 12SEC EBSEmergent BioSolutions Inc. Sell Plan 17,801119,858 held (−13%) $10.54 $188K -39.5%
  • Sell

    Director Donald W Degolyer sold $126K of EBS at $7.09 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Donald W Degolyer sold $121K of EBS at $8.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Donald W Degolyer sold $9K of EBS at $8.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Donald W Degolyer sold $188K of EBS at $10.54 — pre-scheduled 10b5-1 plan sale.